Global Biopharmaceutical Cold Chain Logistics Market Size, Share, Trends, Growth Drivers, Overall Sales and Demand Forecast To 2030

Global Biopharmaceutical Cold Chain Logistics Market Size, Share, Trends, Growth Drivers, Overall Sales and Demand Forecast To 2030
Report Category: Telecom, Computing, Software and IT Services
SKU: PMR-106560  Published Date: 2025-01-27   Pages:109   Delivery Format:


CHOOSE LICENSE TYPE





PMR Research.

Market Executive Summary

It is a temperature-controlled supply system used to transport and store perishable products, such as vaccines, biologics, and drugs.

The global market for Biopharmaceutical Cold Chain Logistics was estimated to be worth US$ 386 million in 2023 and is forecast to a readjusted size of US$ 564.9 million by 2030 with a CAGR of 5.5% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical Cold Chain Logistics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Biopharmaceutical Cold Chain Logistics by region & country, by Type, and by Application.

The Biopharmaceutical Cold Chain Logistics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical Cold Chain Logistics.

Global Biopharmaceutical Cold Chain Logistics Companies Covered

FedEx Corporation, Ceva Logistics LLC, Amerisource Bergen Corporation, Panalpina Group, Kuehne + Nagel International AG, XPO Logistics, Inc, United Parcel Service, Inc, Deutsche Post DHL Group, DB Schenker, C.H. Robinson Worldwide.

Global Biopharmaceutical Cold Chain Logistics Market, by Region

North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Biopharmaceutical Cold Chain Logistics Market, Segment by Type

Airways Cold Chain Logistics

Roadways Cold Chain Logistics

Seaways Cold Chain Logistics

Global Biopharmaceutical Cold Chain Logistics Market, Segment by Application

Food and Beverages

Healthcare

Others

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Biopharmaceutical Cold Chain Logistics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Biopharmaceutical Cold Chain Logistics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Biopharmaceutical Cold Chain Logistics in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.



Table of Contents

1 Market Overview

    1.1 Biopharmaceutical Cold Chain Logistics Product Introduction

    1.2 Global Biopharmaceutical Cold Chain Logistics Market Size Forecast

    1.3 Biopharmaceutical Cold Chain Logistics Market Trends & Drivers

        1.3.1 Biopharmaceutical Cold Chain Logistics Industry Trends

        1.3.2 Biopharmaceutical Cold Chain Logistics Market Drivers & Opportunity

        1.3.3 Biopharmaceutical Cold Chain Logistics Market Challenges

        1.3.4 Biopharmaceutical Cold Chain Logistics Market Restraints

    1.4 Assumptions and Limitations

    1.5 Study Objectives

    1.6 Years Considered

 2 Competitive Analysis by Company

    2.1 Global Biopharmaceutical Cold Chain Logistics Players Revenue Ranking (2023)

    2.2 Global Biopharmaceutical Cold Chain Logistics Revenue by Company (2019-2024)

    2.3 Key Companies Biopharmaceutical Cold Chain Logistics Manufacturing Base Distribution and Headquarters

    2.4 Key Companies Biopharmaceutical Cold Chain Logistics Product Offered

    2.5 Key Companies Time to Begin Mass Production of Biopharmaceutical Cold Chain Logistics

    2.6 Biopharmaceutical Cold Chain Logistics Market Competitive Analysis

        2.6.1 Biopharmaceutical Cold Chain Logistics Market Concentration Rate (2019-2024)

        2.6.2 Global 5 and 10 Largest Companies by Biopharmaceutical Cold Chain Logistics Revenue in 2023

        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Cold Chain Logistics as of 2023)

    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type

    3.1 Introduction by Type

        3.1.1 Airways Cold Chain Logistics

        3.1.2 Roadways Cold Chain Logistics

        3.1.3 Seaways Cold Chain Logistics

    3.2 Global Biopharmaceutical Cold Chain Logistics Sales Value by Type

        3.2.1 Global Biopharmaceutical Cold Chain Logistics Sales Value by Type (2019 VS 2023 VS 2030)

        3.2.2 Global Biopharmaceutical Cold Chain Logistics Sales Value, by Type (2019-2030)

        3.2.3 Global Biopharmaceutical Cold Chain Logistics Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application

    4.1 Introduction by Application

        4.1.1 Food and Beverages

        4.1.2 Healthcare

        4.1.3 Others

    4.2 Global Biopharmaceutical Cold Chain Logistics Sales Value by Application

        4.2.1 Global Biopharmaceutical Cold Chain Logistics Sales Value by Application (2019 VS 2023 VS 2030)

        4.2.2 Global Biopharmaceutical Cold Chain Logistics Sales Value, by Application (2019-2030)

        4.2.3 Global Biopharmaceutical Cold Chain Logistics Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region

    5.1 Global Biopharmaceutical Cold Chain Logistics Sales Value by Region

        5.1.1 Global Biopharmaceutical Cold Chain Logistics Sales Value by Region: 2019 VS 2023 VS 2030

        5.1.2 Global Biopharmaceutical Cold Chain Logistics Sales Value by Region (2019-2024)

        5.1.3 Global Biopharmaceutical Cold Chain Logistics Sales Value by Region (2025-2030)

        5.1.4 Global Biopharmaceutical Cold Chain Logistics Sales Value by Region (%), (2019-2030)

    5.2 North America

        5.2.1 North America Biopharmaceutical Cold Chain Logistics Sales Value, 2019-2030

        5.2.2 North America Biopharmaceutical Cold Chain Logistics Sales Value by Country (%), 2023 VS 2030

    5.3 Europe

        5.3.1 Europe Biopharmaceutical Cold Chain Logistics Sales Value, 2019-2030

        5.3.2 Europe Biopharmaceutical Cold Chain Logistics Sales Value by Country (%), 2023 VS 2030

    5.4 Asia Pacific

        5.4.1 Asia Pacific Biopharmaceutical Cold Chain Logistics Sales Value, 2019-2030

        5.4.2 Asia Pacific Biopharmaceutical Cold Chain Logistics Sales Value by Country (%), 2023 VS 2030

    5.5 South America

        5.5.1 South America Biopharmaceutical Cold Chain Logistics Sales Value, 2019-2030

        5.5.2 South America Biopharmaceutical Cold Chain Logistics Sales Value by Country (%), 2023 VS 2030

    5.6 Middle East & Africa

        5.6.1 Middle East & Africa Biopharmaceutical Cold Chain Logistics Sales Value, 2019-2030

        5.6.2 Middle East & Africa Biopharmaceutical Cold Chain Logistics Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions

    6.1 Key Countries/Regions Biopharmaceutical Cold Chain Logistics Sales Value Growth Trends, 2019 VS 2023 VS 2030

    6.2 Key Countries/Regions Biopharmaceutical Cold Chain Logistics Sales Value

    6.3 United States

        6.3.1 United States Biopharmaceutical Cold Chain Logistics Sales Value, 2019-2030

        6.3.2 United States Biopharmaceutical Cold Chain Logistics Sales Value by Type (%), 2023 VS 2030

        6.3.3 United States Biopharmaceutical Cold Chain Logistics Sales Value by Application, 2023 VS 2030

    6.4 Europe

        6.4.1 Europe Biopharmaceutical Cold Chain Logistics Sales Value, 2019-2030

        6.4.2 Europe Biopharmaceutical Cold Chain Logistics Sales Value by Type (%), 2023 VS 2030

        6.4.3 Europe Biopharmaceutical Cold Chain Logistics Sales Value by Application, 2023 VS 2030

    6.5 China

        6.5.1 China Biopharmaceutical Cold Chain Logistics Sales Value, 2019-2030

        6.5.2 China Biopharmaceutical Cold Chain Logistics Sales Value by Type (%), 2023 VS 2030

        6.5.3 China Biopharmaceutical Cold Chain Logistics Sales Value by Application, 2023 VS 2030

    6.6 Japan

        6.6.1 Japan Biopharmaceutical Cold Chain Logistics Sales Value, 2019-2030

        6.6.2 Japan Biopharmaceutical Cold Chain Logistics Sales Value by Type (%), 2023 VS 2030

        6.6.3 Japan Biopharmaceutical Cold Chain Logistics Sales Value by Application, 2023 VS 2030

    6.7 South Korea

        6.7.1 South Korea Biopharmaceutical Cold Chain Logistics Sales Value, 2019-2030

        6.7.2 South Korea Biopharmaceutical Cold Chain Logistics Sales Value by Type (%), 2023 VS 2030

        6.7.3 South Korea Biopharmaceutical Cold Chain Logistics Sales Value by Application, 2023 VS 2030

    6.8 Southeast Asia

        6.8.1 Southeast Asia Biopharmaceutical Cold Chain Logistics Sales Value, 2019-2030

        6.8.2 Southeast Asia Biopharmaceutical Cold Chain Logistics Sales Value by Type (%), 2023 VS 2030

        6.8.3 Southeast Asia Biopharmaceutical Cold Chain Logistics Sales Value by Application, 2023 VS 2030

    6.9 India

        6.9.1 India Biopharmaceutical Cold Chain Logistics Sales Value, 2019-2030

        6.9.2 India Biopharmaceutical Cold Chain Logistics Sales Value by Type (%), 2023 VS 2030

        6.9.3 India Biopharmaceutical Cold Chain Logistics Sales Value by Application, 2023 VS 2030

 7 Company Profiles

    7.1 FedEx Corporation

        7.1.1 FedEx Corporation Profile

        7.1.2 FedEx Corporation Main Business

        7.1.3 FedEx Corporation Biopharmaceutical Cold Chain Logistics Products, Services and Solutions

        7.1.4 FedEx Corporation Biopharmaceutical Cold Chain Logistics Revenue (US$ Million) & (2019-2024)

        7.1.5 FedEx Corporation Recent Developments

    7.2 Ceva Logistics LLC

        7.2.1 Ceva Logistics LLC Profile

        7.2.2 Ceva Logistics LLC Main Business

        7.2.3 Ceva Logistics LLC Biopharmaceutical Cold Chain Logistics Products, Services and Solutions

        7.2.4 Ceva Logistics LLC Biopharmaceutical Cold Chain Logistics Revenue (US$ Million) & (2019-2024)

        7.2.5 Ceva Logistics LLC Recent Developments

    7.3 Amerisource Bergen Corporation

        7.3.1 Amerisource Bergen Corporation Profile

        7.3.2 Amerisource Bergen Corporation Main Business

        7.3.3 Amerisource Bergen Corporation Biopharmaceutical Cold Chain Logistics Products, Services and Solutions

        7.3.4 Amerisource Bergen Corporation Biopharmaceutical Cold Chain Logistics Revenue (US$ Million) & (2019-2024)

        7.3.5 Panalpina Group Recent Developments

    7.4 Panalpina Group

        7.4.1 Panalpina Group Profile

        7.4.2 Panalpina Group Main Business

        7.4.3 Panalpina Group Biopharmaceutical Cold Chain Logistics Products, Services and Solutions

        7.4.4 Panalpina Group Biopharmaceutical Cold Chain Logistics Revenue (US$ Million) & (2019-2024)

        7.4.5 Panalpina Group Recent Developments

    7.5 Kuehne + Nagel International AG

        7.5.1 Kuehne + Nagel International AG Profile

        7.5.2 Kuehne + Nagel International AG Main Business

        7.5.3 Kuehne + Nagel International AG Biopharmaceutical Cold Chain Logistics Products, Services and Solutions

        7.5.4 Kuehne + Nagel International AG Biopharmaceutical Cold Chain Logistics Revenue (US$ Million) & (2019-2024)

        7.5.5 Kuehne + Nagel International AG Recent Developments

    7.6 XPO Logistics, Inc

        7.6.1 XPO Logistics, Inc Profile

        7.6.2 XPO Logistics, Inc Main Business

        7.6.3 XPO Logistics, Inc Biopharmaceutical Cold Chain Logistics Products, Services and Solutions

        7.6.4 XPO Logistics, Inc Biopharmaceutical Cold Chain Logistics Revenue (US$ Million) & (2019-2024)

        7.6.5 XPO Logistics, Inc Recent Developments

    7.7 United Parcel Service, Inc

        7.7.1 United Parcel Service, Inc Profile

        7.7.2 United Parcel Service, Inc Main Business

        7.7.3 United Parcel Service, Inc Biopharmaceutical Cold Chain Logistics Products, Services and Solutions

        7.7.4 United Parcel Service, Inc Biopharmaceutical Cold Chain Logistics Revenue (US$ Million) & (2019-2024)

        7.7.5 United Parcel Service, Inc Recent Developments

    7.8 Deutsche Post DHL Group

        7.8.1 Deutsche Post DHL Group Profile

        7.8.2 Deutsche Post DHL Group Main Business

        7.8.3 Deutsche Post DHL Group Biopharmaceutical Cold Chain Logistics Products, Services and Solutions

        7.8.4 Deutsche Post DHL Group Biopharmaceutical Cold Chain Logistics Revenue (US$ Million) & (2019-2024)

        7.8.5 Deutsche Post DHL Group Recent Developments

    7.9 DB Schenker

        7.9.1 DB Schenker Profile

        7.9.2 DB Schenker Main Business

        7.9.3 DB Schenker Biopharmaceutical Cold Chain Logistics Products, Services and Solutions

        7.9.4 DB Schenker Biopharmaceutical Cold Chain Logistics Revenue (US$ Million) & (2019-2024)

        7.9.5 DB Schenker Recent Developments

    7.10 C.H. Robinson Worldwide

        7.10.1 C.H. Robinson Worldwide Profile

        7.10.2 C.H. Robinson Worldwide Main Business

        7.10.3 C.H. Robinson Worldwide Biopharmaceutical Cold Chain Logistics Products, Services and Solutions

        7.10.4 C.H. Robinson Worldwide Biopharmaceutical Cold Chain Logistics Revenue (US$ Million) & (2019-2024)

        7.10.5 C.H. Robinson Worldwide Recent Developments

 8 Industry Chain Analysis

    8.1 Biopharmaceutical Cold Chain Logistics Industrial Chain

    8.2 Biopharmaceutical Cold Chain Logistics Upstream Analysis

        8.2.1 Key Raw Materials

        8.2.2 Raw Materials Key Suppliers

        8.2.3 Manufacturing Cost Structure

    8.3 Midstream Analysis

    8.4 Downstream Analysis (Customers Analysis)

    8.5 Sales Model and Sales Channels

        8.5.1 Biopharmaceutical Cold Chain Logistics Sales Model

        8.5.2 Sales Channel

        8.5.3 Biopharmaceutical Cold Chain Logistics Distributors

 9 Research Findings and Conclusion

 10 Appendix

    10.1 Research Methodology

        10.1.1 Methodology/Research Approach

        10.1.2 Data Source

    10.2 Author Details

    10.3 Disclaimer



List of Figures

List of Tables

    Table 1. Biopharmaceutical Cold Chain Logistics Market Trends

    Table 2. Biopharmaceutical Cold Chain Logistics Market Drivers & Opportunity

    Table 3. Biopharmaceutical Cold Chain Logistics Market Challenges

    Table 4. Biopharmaceutical Cold Chain Logistics Market Restraints

    Table 5. Global Biopharmaceutical Cold Chain Logistics Revenue by Company (2019-2024) & (US$ Million)

    Table 6. Global Biopharmaceutical Cold Chain Logistics Revenue Market Share by Company (2019-2024)

    Table 7. Key Companies Biopharmaceutical Cold Chain Logistics Manufacturing Base Distribution and Headquarters

    Table 8. Key Companies Biopharmaceutical Cold Chain Logistics Product Type

    Table 9. Key Companies Time to Begin Mass Production of Biopharmaceutical Cold Chain Logistics

    Table 10. Global Biopharmaceutical Cold Chain Logistics Companies Market Concentration Ratio (CR5 and HHI)

    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Cold Chain Logistics as of 2023)

    Table 12. Mergers & Acquisitions, Expansion Plans

    Table 13. Global Biopharmaceutical Cold Chain Logistics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

    Table 14. Global Biopharmaceutical Cold Chain Logistics Sales Value by Type (2019-2024) & (US$ Million)

    Table 15. Global Biopharmaceutical Cold Chain Logistics Sales Value by Type (2025-2030) & (US$ Million)

    Table 16. Global Biopharmaceutical Cold Chain Logistics Sales Market Share in Value by Type (2019-2024) & (%)

    Table 17. Global Biopharmaceutical Cold Chain Logistics Sales Market Share in Value by Type (2025-2030) & (%)

    Table 18. Global Biopharmaceutical Cold Chain Logistics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

    Table 19. Global Biopharmaceutical Cold Chain Logistics Sales Value by Application (2019-2024) & (US$ Million)

    Table 20. Global Biopharmaceutical Cold Chain Logistics Sales Value by Application (2025-2030) & (US$ Million)

    Table 21. Global Biopharmaceutical Cold Chain Logistics Sales Market Share in Value by Application (2019-2024) & (%)

    Table 22. Global Biopharmaceutical Cold Chain Logistics Sales Market Share in Value by Application (2025-2030) & (%)

    Table 23. Global Biopharmaceutical Cold Chain Logistics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

    Table 24. Global Biopharmaceutical Cold Chain Logistics Sales Value by Region (2019-2024) & (US$ Million)

    Table 25. Global Biopharmaceutical Cold Chain Logistics Sales Value by Region (2025-2030) & (US$ Million)

    Table 26. Global Biopharmaceutical Cold Chain Logistics Sales Value by Region (2019-2024) & (%)

    Table 27. Global Biopharmaceutical Cold Chain Logistics Sales Value by Region (2025-2030) & (%)

    Table 28. Key Countries/Regions Biopharmaceutical Cold Chain Logistics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

    Table 29. Key Countries/Regions Biopharmaceutical Cold Chain Logistics Sales Value, (2019-2024) & (US$ Million)

    Table 30. Key Countries/Regions Biopharmaceutical Cold Chain Logistics Sales Value, (2025-2030) & (US$ Million)

    Table 31. FedEx Corporation Basic Information List

    Table 32. FedEx Corporation Description and Business Overview

    Table 33. FedEx Corporation Biopharmaceutical Cold Chain Logistics Products, Services and Solutions

    Table 34. Revenue (US$ Million) in Biopharmaceutical Cold Chain Logistics Business of FedEx Corporation (2019-2024)

    Table 35. FedEx Corporation Recent Developments

    Table 36. Ceva Logistics LLC Basic Information List

    Table 37. Ceva Logistics LLC Description and Business Overview

    Table 38. Ceva Logistics LLC Biopharmaceutical Cold Chain Logistics Products, Services and Solutions

    Table 39. Revenue (US$ Million) in Biopharmaceutical Cold Chain Logistics Business of Ceva Logistics LLC (2019-2024)

    Table 40. Ceva Logistics LLC Recent Developments

    Table 41. Amerisource Bergen Corporation Basic Information List

    Table 42. Amerisource Bergen Corporation Description and Business Overview

    Table 43. Amerisource Bergen Corporation Biopharmaceutical Cold Chain Logistics Products, Services and Solutions

    Table 44. Revenue (US$ Million) in Biopharmaceutical Cold Chain Logistics Business of Amerisource Bergen Corporation (2019-2024)

    Table 45. Amerisource Bergen Corporation Recent Developments

    Table 46. Panalpina Group Basic Information List

    Table 47. Panalpina Group Description and Business Overview

    Table 48. Panalpina Group Biopharmaceutical Cold Chain Logistics Products, Services and Solutions

    Table 49. Revenue (US$ Million) in Biopharmaceutical Cold Chain Logistics Business of Panalpina Group (2019-2024)

    Table 50. Panalpina Group Recent Developments

    Table 51. Kuehne + Nagel International AG Basic Information List

    Table 52. Kuehne + Nagel International AG Description and Business Overview

    Table 53. Kuehne + Nagel International AG Biopharmaceutical Cold Chain Logistics Products, Services and Solutions

    Table 54. Revenue (US$ Million) in Biopharmaceutical Cold Chain Logistics Business of Kuehne + Nagel International AG (2019-2024)

    Table 55. Kuehne + Nagel International AG Recent Developments

    Table 56. XPO Logistics, Inc Basic Information List

    Table 57. XPO Logistics, Inc Description and Business Overview

    Table 58. XPO Logistics, Inc Biopharmaceutical Cold Chain Logistics Products, Services and Solutions

    Table 59. Revenue (US$ Million) in Biopharmaceutical Cold Chain Logistics Business of XPO Logistics, Inc (2019-2024)

    Table 60. XPO Logistics, Inc Recent Developments

    Table 61. United Parcel Service, Inc Basic Information List

    Table 62. United Parcel Service, Inc Description and Business Overview

    Table 63. United Parcel Service, Inc Biopharmaceutical Cold Chain Logistics Products, Services and Solutions

    Table 64. Revenue (US$ Million) in Biopharmaceutical Cold Chain Logistics Business of United Parcel Service, Inc (2019-2024)

    Table 65. United Parcel Service, Inc Recent Developments

    Table 66. Deutsche Post DHL Group Basic Information List

    Table 67. Deutsche Post DHL Group Description and Business Overview

    Table 68. Deutsche Post DHL Group Biopharmaceutical Cold Chain Logistics Products, Services and Solutions

    Table 69. Revenue (US$ Million) in Biopharmaceutical Cold Chain Logistics Business of Deutsche Post DHL Group (2019-2024)

    Table 70. Deutsche Post DHL Group Recent Developments

    Table 71. DB Schenker Basic Information List

    Table 72. DB Schenker Description and Business Overview

    Table 73. DB Schenker Biopharmaceutical Cold Chain Logistics Products, Services and Solutions

    Table 74. Revenue (US$ Million) in Biopharmaceutical Cold Chain Logistics Business of DB Schenker (2019-2024)

    Table 75. DB Schenker Recent Developments

    Table 76. C.H. Robinson Worldwide Basic Information List

    Table 77. C.H. Robinson Worldwide Description and Business Overview

    Table 78. C.H. Robinson Worldwide Biopharmaceutical Cold Chain Logistics Products, Services and Solutions

    Table 79. Revenue (US$ Million) in Biopharmaceutical Cold Chain Logistics Business of C.H. Robinson Worldwide (2019-2024)

    Table 80. C.H. Robinson Worldwide Recent Developments

    Table 81. Key Raw Materials Lists

    Table 82. Raw Materials Key Suppliers Lists

    Table 83. Biopharmaceutical Cold Chain Logistics Downstream Customers

    Table 84. Biopharmaceutical Cold Chain Logistics Distributors List

    Table 85. Research Programs/Design for This Report

    Table 86. Key Data Information from Secondary Sources

    Table 87. Key Data Information from Primary Sources

    Table 88. Business Unit and Senior & Team Lead Analysts

List of Figures

    Figure 1. Biopharmaceutical Cold Chain Logistics Product Picture

    Figure 2. Global Biopharmaceutical Cold Chain Logistics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

    Figure 3. Global Biopharmaceutical Cold Chain Logistics Sales Value (2019-2030) & (US$ Million)

    Figure 4. Biopharmaceutical Cold Chain Logistics Report Years Considered

    Figure 5. Global Biopharmaceutical Cold Chain Logistics Players Revenue Ranking (2023) & (US$ Million)

    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Biopharmaceutical Cold Chain Logistics Revenue in 2023

    Figure 7. Biopharmaceutical Cold Chain Logistics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

    Figure 8. Airways Cold Chain Logistics Picture

    Figure 9. Roadways Cold Chain Logistics Picture

    Figure 10. Seaways Cold Chain Logistics Picture

    Figure 11. Global Biopharmaceutical Cold Chain Logistics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

    Figure 12. Global Biopharmaceutical Cold Chain Logistics Sales Value Market Share by Type, 2023 & 2030

    Figure 13. Product Picture of Food and Beverages

    Figure 14. Product Picture of Healthcare

    Figure 15. Product Picture of Others

    Figure 16. Global Biopharmaceutical Cold Chain Logistics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

    Figure 17. Global Biopharmaceutical Cold Chain Logistics Sales Value Market Share by Application, 2023 & 2030

    Figure 18. North America Biopharmaceutical Cold Chain Logistics Sales Value (2019-2030) & (US$ Million)

    Figure 19. North America Biopharmaceutical Cold Chain Logistics Sales Value by Country (%), 2023 VS 2030

    Figure 20. Europe Biopharmaceutical Cold Chain Logistics Sales Value (2019-2030) & (US$ Million)

    Figure 21. Europe Biopharmaceutical Cold Chain Logistics Sales Value by Country (%), 2023 VS 2030

    Figure 22. Asia Pacific Biopharmaceutical Cold Chain Logistics Sales Value (2019-2030) & (US$ Million)

    Figure 23. Asia Pacific Biopharmaceutical Cold Chain Logistics Sales Value by Country (%), 2023 VS 2030

    Figure 24. South America Biopharmaceutical Cold Chain Logistics Sales Value (2019-2030) & (US$ Million)

    Figure 25. South America Biopharmaceutical Cold Chain Logistics Sales Value by Country (%), 2023 VS 2030

    Figure 26. Middle East & Africa Biopharmaceutical Cold Chain Logistics Sales Value (2019-2030) & (US$ Million)

    Figure 27. Middle East & Africa Biopharmaceutical Cold Chain Logistics Sales Value by Country (%), 2023 VS 2030

    Figure 28. Key Countries/Regions Biopharmaceutical Cold Chain Logistics Sales Value (%), (2019-2030)

    Figure 29. United States Biopharmaceutical Cold Chain Logistics Sales Value, (2019-2030) & (US$ Million)

    Figure 30. United States Biopharmaceutical Cold Chain Logistics Sales Value by Type (%), 2023 VS 2030

    Figure 31. United States Biopharmaceutical Cold Chain Logistics Sales Value by Application (%), 2023 VS 2030

    Figure 32. Europe Biopharmaceutical Cold Chain Logistics Sales Value, (2019-2030) & (US$ Million)

    Figure 33. Europe Biopharmaceutical Cold Chain Logistics Sales Value by Type (%), 2023 VS 2030

    Figure 34. Europe Biopharmaceutical Cold Chain Logistics Sales Value by Application (%), 2023 VS 2030

    Figure 35. China Biopharmaceutical Cold Chain Logistics Sales Value, (2019-2030) & (US$ Million)

    Figure 36. China Biopharmaceutical Cold Chain Logistics Sales Value by Type (%), 2023 VS 2030

    Figure 37. China Biopharmaceutical Cold Chain Logistics Sales Value by Application (%), 2023 VS 2030

    Figure 38. Japan Biopharmaceutical Cold Chain Logistics Sales Value, (2019-2030) & (US$ Million)

    Figure 39. Japan Biopharmaceutical Cold Chain Logistics Sales Value by Type (%), 2023 VS 2030

    Figure 40. Japan Biopharmaceutical Cold Chain Logistics Sales Value by Application (%), 2023 VS 2030

    Figure 41. South Korea Biopharmaceutical Cold Chain Logistics Sales Value, (2019-2030) & (US$ Million)

    Figure 42. South Korea Biopharmaceutical Cold Chain Logistics Sales Value by Type (%), 2023 VS 2030

    Figure 43. South Korea Biopharmaceutical Cold Chain Logistics Sales Value by Application (%), 2023 VS 2030

    Figure 44. Southeast Asia Biopharmaceutical Cold Chain Logistics Sales Value, (2019-2030) & (US$ Million)

    Figure 45. Southeast Asia Biopharmaceutical Cold Chain Logistics Sales Value by Type (%), 2023 VS 2030

    Figure 46. Southeast Asia Biopharmaceutical Cold Chain Logistics Sales Value by Application (%), 2023 VS 2030

    Figure 47. India Biopharmaceutical Cold Chain Logistics Sales Value, (2019-2030) & (US$ Million)

    Figure 48. India Biopharmaceutical Cold Chain Logistics Sales Value by Type (%), 2023 VS 2030

    Figure 49. India Biopharmaceutical Cold Chain Logistics Sales Value by Application (%), 2023 VS 2030

    Figure 50. Biopharmaceutical Cold Chain Logistics Industrial Chain

    Figure 51. Biopharmaceutical Cold Chain Logistics Manufacturing Cost Structure

    Figure 52. Channels of Distribution (Direct Sales, and Distribution)

    Figure 53. Bottom-up and Top-down Approaches for This Report

    Figure 54. Data Triangulation


We can offer customized data and information to meet our clients need.

This report focuses on:

► Intelligent insights to take informed business decisions.

► Qualitative and quantitative analysis of the market.

► Market size and forecasts from 2024 to 2030.

► Opportunities for expansion and in-depth market analysis.

► Segmentation and regional revenue forecasts.

► Analysis of the market share and competitive landscape.

► Strategic recommendations for future growth.


You'll also receive:

► A comprehensive market research report in PDF or PPT formats.

► Access to our analysts to learn more about the report and get answers to your specific business questions.

► The option to customize the report to meet your specific needs, such as adding more countries or regions or developing abusiness case to launch a new product.


Contact us today to learn more and get sample report.


Our Research Reports Look Like This
Pragma Market Research Sample

Covid-19 Impact Duns and Brad Badge
up